COMP <GO>
TECH vs TWST // 10Y YIELD & FRED MACRO BETA
Bio-Techne Corp (NASDAQ) VS. Twist Bioscience Corporation (NASDAQ) • 15-METRIC TALLY: TECH 7
— TWST 6
▲ 10Y YIELD & FRED MACRO BETA LEADER: TWST
LAST: $72.66 (-0.07%) • MKT CAP: $11.40B
macro-sensitivity
0.88
LAST: $152.78 (-11.92%) • MKT CAP: $11.50B
macro-sensitivity
0.98
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TECH VS. TWST)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TECH | TWST | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 64.80% | 94.20% | -29.40 | TWST | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | -11.70% | +15.10 | TECH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 91.3x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.25% | -0.66% | +2.91 | TECH | /fcf-yield <GO> |
| Operating Margin | 8.40% | -4.20% | +12.60 | TECH | /operating-margins <GO> |
| Net Profit Margin | 6.00% | -2.40% | +8.40 | TECH | /net-margins <GO> |
| Revenue Growth (YoY) | 5.20% | 16.50% | -11.30 | TWST | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.44% | 0.00% | +0.44 | TECH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.12 | 26.00 | -18.88 | TWST | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 6/9 | +2.00 | TECH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 59.3 | 57.2 | +2.10 | TECH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.88 | 0.98 | -0.10 | TWST | /macro-sensitivity <GO> |
| Forward P/E Multiple | 140.0x | 21.0x | +119.00 | TWST | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $11.40B | $11.50B | -$97.7M | TWST | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TECH REV | TWST REV | TECH GROSS % | TWST GROSS % | TECH FCF | TWST FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.22B | $0 | 64.8% | — | $256.6M | -$75.6M |
| FY 2024 | $1.16B | $0 | 66.4% | — | $236.1M | -$69.2M |
| FY 2023 | $1.14B | $0 | — | — | $203.2M | -$142.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TECH // BETA 0.88
TWST // BETA 0.98